EMERGERS
Equity Research of
Nordic Growth Companies
EMERGERS
Equity Research of
Nordic Growth Companies
The arrival of the first commercial prototype instruments for Prolight’s Psyros Point of Care...
Prolight continues to make progress with its proprietary Psyros platform, with a pre-validation...
NEX-22 is progressing as expected, with the last patient in Phase I treated, results anticipated...
On Friday Nov 1st, 2024 Crunchfish hosted a webinar in connection with the Q3’24 report,...
RESEARCH COLLABORATION WITH ENLIGHT RESEARCH Q3 Sales and Profits beat estimates, but the...
As discussed in our previous update, Crunchfish has now settled on a path forward for the...
With the dust settling after the acquisition of Sydvaranger and the updated DFS for Dannemora in...
MODI reported Q2’24 sales largely in line with last year, at SEK 7.4m compared to SEK 7.6m in...
